See below for the presentation slides from
Allison Vordenbaumen Benz, R.Ph., M.S.
Texas State Board of Pharmacy
Presented on February 4, 2021 to Dallas Area Pharmacy Association.
|DAPA would like to invite you to an upcoming virtual program from Merck Oncology, entitled:
Discussing Anti-cancer Therapy Along With Patient Monitoring and Management of Adverse Events.
|Below is the speaker presenting for this program.
Dr. Eric Nadler
You will be receiving an email from DAPA with our announcements and updates from DAPA President, Jeff Loesch, before the program.
Understand the mechanism of action of a current anticancer therapy
Identify what to monitor and how to manage adverse reactions associated with an anticancer therapy
Discuss a clinical case highlighting management of selected adverse reactions
|Click below to review event dates and to register.|
|CLICK HERE TO REGISTER|
|As you click on the link above, you will be able to review the program options and register accordingly. Merck is pleased to sponsor this program. This program is not an accredited CME program and is not designed to meet any training and/or educational requirements.If you have any questions about this event, please email or call me at your convenience. I look forward to speaking with you soon.Regards,Nicole
+1 (972) 9745722
|Felicia Nicole Joe
Merck Customer Representative